Bing

SEARCH HISTORY

Healthcare stocks finished up 0.6% on Wall Street today. More broadly, the Dow Jones Industrial Average declined 0.2%, the Nasdaq was down 0.1% and the S&P 500 fell 0.2%. Some of the biggest gainers among healthcare stocks include: Theravance …
Investor Place · 8/1/2015
Trade-Ideas LLC identified ARIAD Pharmaceuticals ( ARIA) as a strong on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified ARIAD Pharmaceuticals as such a stock due to the following factors: ARIA has an ...
The Street · 7/28/2015
Ariad Pharmaceuticals (NASDAQ:ARIA)‘s stock had its “market perform” rating restated by stock analysts at Cowen and Company in a report issued on Tuesday, AnalystRatingsNetwork.com reports. Shares of Ariad Pharmaceuticals (NASDAQ:ARIA) …
Mideast Times · 7/22/2015
More from Bing News
Safety concerns for Ariad Pharmaceuticals' (NASDAQ:ARIA) Iclusig resulted in a temporary suspension ... it's hard for me to recommend this stock to anyone other than someone who could accept the risk of a …
The Motley Fool · 7/24/2015
Ariad Pharmaceuticals
Ariad Pharmaceuticals (NASDAQ:ARIA)‘s stock had its “market perform” rating reaffirmed by equities research analysts at Cowen and Company in a research note issued to investors on Tuesday, Marketbeat reports. In other Ariad Pharmaceuticals …
Ticker Report · 7/21/2015
CHICAGO, July 29, 2015 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SDRL, AMGN, ARIA, JCI and ACAD. To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by …
Market Watch · 7/29/2015
The stock was sold at an average price of $8.54, for a total transaction of $34,160.00. The disclosure for this sale can be found here. Shares of Ariad Pharmaceuticals (NASDAQ:ARIA) traded down 0.95% during mid-day trading on Tuesday, hitting $8.33.
sleekmoney.com · 7/21/2015
Ariad Pharmaceuticals
One of today's stocks on the move is Ariad Pharmaceuticals (NASDAQ:ARIA), down 1.8% to $7.56. The Dow is down 0.7% to 17,447 and the S&P is currently down 0.4% to 2,071. In the past 52 weeks, Ariad Pharmaceuticals share prices have been …
Financial News Network Online · ByAdrienne Chilton · 7/27/2015
The stock was down 4.8 percent in early morning trading ... The trial has shown a side effect known as ARIA, for amyloid-related imaging abnormalities, associated with removal of plaques from the brain. Biogen said in …
CNBC · 7/22/2015
Eli Lilly
July 29, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (NASDAQ: PDLI) today announced that it has entered into a revenue interest assignment agreement (the "Agreement") in which it has agreed to provide ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) …
Financial Content · 7/29/2015
PDL